Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): Implications for nutritional transcriptomics and multi-target therapy

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1395-1404

  Noori Daloii, Mohammad R ^a   Momeny, Majid ^b   Yousefi, Mehdi ^c   Shirazi, Forough Golsaz ^c   Yaseri, Mehdi ^c   Motamed, Nasrin ^d   Kazemialiakbar, Nazanin ^d   Hashemi, Saeed ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Multi target therapy; Nutritional transcriptomics; Prostate cancer (PCa); Quercetin; Real time PCR array

Indexed keywords

ATM PROTEIN; BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; HEPARANASE; HISTONE DEACETYLASE 4; INOSINATE DEHYDROGENASE; LACTATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NUCLEOSIDE DIPHOSPHATE KINASE NM23; OSTEOPONTIN; PERLECAN; QUERCETIN; SODIUM PROTON EXCHANGE PROTEIN 1; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CYCLE; CELL PROLIFERATION; CYTOTOXICITY; DNA REPAIR; DRUG INHIBITION; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; NUTRITIONAL TRANSCRIPTOMICS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; GENE EXPRESSION; HUMANS; MALE; PROSTATIC NEOPLASMS; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84555208787     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9603-3     Document Type: Article

References (92)

1. A Jemal R Siegel E Ward Y Hao J Xu 2008 Cancer statistics, 2008 CA Cancer J Clin 58 67 125
2. WG Nelson AM De Marzo WB Isaacs 2003 Mechanisms of disease: prostate cancer New Eng J Med 349 366 381
3. E Deutsch L Maggiorella P Eschwege J Bourhis J Soria 2004 Environmental, genetic, and molecular features of prostate cancer Lancet Oncol 5 303 313
4. K Porkka T Visakorpi 2004 Molecular mechanisms of prostate cancer Eur Urol 45 683 691
5. H Grönberg 2003 Prostate cancer epidemiology Lancet 361 859 864
6. CS Muir J Nectoux J Staszewski 1991 The epidemiology of prostatic cancer. Geographical distribution and time-trends Acta Oncol 30 133 140
7. H Shimizu RK Ross L Bernstein R Yatani BE Henderson TM Mack 1991 Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County Br J Cancer 63 963 969
8. ML Neuhouser 2004 Dietary flavonoids and cancer risk: evidence from human population studies Nutr Cancer 50 1 7
9. WJ Craig 1997 Phytochemicals: guardians of our health J Am Diet Assoc 97 S199 S204
10. H Adlercreutz W Mazur P Bartels VV Elomaa S Watanabe 2000 Phytoestrogens and prostate disease J Nutr 130 658S 659S
11. J Lampe 2003 Isoflavonoid and lignan phytoestrogens as dietary biomarkers J Nutr 133 956S 964S
12. SA Aherne NM O'Brien 2002 Dietary flavonols: chemistry, food content, and metabolism Nutrition 18 75 81
13. MG Hertog PC Hollman MB Katan 1992 Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands J Agric Food Chem 40 2379 2383
14. AQ Haddad V Venkateswaran L Viswanathan SJ Teahan NE Fleshner 2006 Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines Prostate Cancer Prostatic Dis 9 68 76
15. P Knekt J Kumpulainen R Jarvinen H Rissanen M Heliovaara 2002 Flavonoid intake and risk of chronic diseases Am J Clin Nutr 76 560 568
16. R Garcia-Closas A Agudo CA Gonzalez E Riboli 1998 Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain Nutr Cancer 32 154 158
17. E De Stefani P Boffetta H Deneo-Pellegrini M Mendilaharsu JC Carzoglio 1999 Dietary antioxidants and lung cancer risk: a case-control study in Uruguay Nutr Cancer 34 100 110
18. R Garcia CA Gonzalez A Agudo E Riboli 1999 High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer Nutr Cancer 35 212 214
19. R Garcia-Closas CA Gonzalez A Agudo E Riboli 1999 Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain Cancer Causes Control 10 71 75
20. L Le Marchand SP Murphy JH Hankin LR Wilkens LN Kolonel 2000 Intake of flavonoids and lung cancer JNCI 92 154 160
21. J Peterson P Lagiou E Samoli A Lagiou K Katsouyanni 2003 Flavonoid intake and breast cancer risk: a case-control study in Greece Br J Cancer 89 1255 1259
22. N Xing Y Chen SH Mitchell CY Young 2001 Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells Carcinogenesis 22 409 414
23. HK Nair KV Rao R Aalinkeel S Mahajan R Chawda 2004 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes Clin Diagn Lab Immunol 11 63 69
24. MR Vijayababu P Kanagaraj A Arunkumar R Ilangovan A Dharmarajan 2006 Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2-related proteins: a possible mediation by IGFBP-3 Oncol Res 16 67 74
25. MR Vijayababu A Arunkumar P Kanagaraj P Venkataraman G Krishnamoorthy 2006 Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3) Mol Cell Biochem 287 109 116
26. K Brusselmans R Vrolix G Verhoeven JV Swinnen 2005 Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity J Biol Chem 280 5636 5645
27. NS Shenouda C Zhou JD Browning PJ Ansell MS Sakla 2004 Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro Nutr Cancer 49 200 208
28. J Morris R Pramanik X Zhang A Carey N Ragavan 2006 Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity Cancer Lett 239 111 122
29. DM Mutch W Wahli G Williamson 2005 Nutrigenomics and nutrigenetics. The emerging faces of nutrition FASEB J 19 1602 1616
30. M Muller S Kersten 2003 Nutrigenomics: goals and strategies Nat Rev Cancer 4 315 322
31. T Helleday E Petermann C Lundin B Hodgson RA Sharma 2008 DNA repair pathways as targets for cancer therapy Nat Rev Cancer 8 180 192
32. S Hakomi 1996 Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism Cancer Res 56 5309 5318
33. L Vlodavski O Goldshmidta E Zchariaa S Metzgerb T Chajek-Shaulb 2001 Molecular properties and involvement of heparanase in cancer progression and normal development Biochimie 83 831 839
34. X Jiang JR Couchman 2003 Perlecan and tumor angiogenesis J Histochem Cytochem 51 1393 1410
35. YY Liu T Han AE Giuliano MC Cabot 2001 Ceramide glycosylation potentiates cellular multidrug resistance FASEB J 15 719 730
36. SG Payne S Milstien S Spiegel 2003 Sphingosine-1-phosphate: dual messenger functions FEBS Lett 531 54 57
37. P Santana LA Pen A Haimovitz-Friedman S Martin D Green 1996 Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis Cell 86 189 199
38. K Brusselmans E De Schrijver G Verhoeven JV Swinnen 2005 RNA interference-mediated silencing of the acetyl-CoA carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells Cancer Res 65 6719 6725
39. C Priolo D Tang M Brahamandan B Benassi E Sicinska 2006 The isopeptidase USP2a protects human prostate cancer from apoptosis Cancer Res 66 8625 8632
40. RA Gatenby RJ Gillies 2004 Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 891 899
41. G Hatzivassiliou F Zhao D Bauer C Andreadis A Shaw 2005 ATP citrate lyase inhibition can suppress tumor cell growth Cancer Cell 8 311 321
42. JA Menendez R Lupu 2007 Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 763 777
43. O Berezovskaya AD Schimmer AB Glinskii C Pinilla RM Hoffman 2005 Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells Cancer Res 65 2378 2386
44. M Zhang DE Latham MA Delaney A Chakravarti 2005 Survivin mediates resistance to antiandrogen therapy in prostate cancer Oncogene 24 2474 2482
45. H O'Kane C Watson S Johnston I Petak R William 2006 Targeting death receptors in bladder, prostate and renal cancer J Urol 175 432 438
46. SD Catz JL Johnson 2004 BCL-2 in prostate cancer: a minireview Apoptosis 8 29 37
47. M Abe JB Manola WK Oh DL Parslow DJ George 2004 Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer Clin Prostate Cancer 3 49 53
48. J Isaacs W Xu L Neckers 2003 Heat shock protein 90 as a molecular target for cancer therapeutics Cancer Cell 3 213 217
49. G Xia SR Kumar R Masood S Zhu R Reddy 2005 EphB4 expression and biological significance in prostate cancer Cancer Res 65 4623 4632
50. B Nicholson D Teodorescu 2003 Angiogenesis and prostate cancer tumor growth J Cell Biochem 91 125 150
51. YR Lawrence AP Dicker 2008 Hypoxia in prostate cancer: observation to intervention Lancet Oncol 9 308 309
52. SR Morey DJ Smiraglia SR James J Yu MT Moser 2006 DNA methylation pathway alterations in an autochthonous murine model of prostate cancer Cancer Res 66 11659 11667
53. K Halkidou 2005 Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate Euro Urol 45 382 389
54. RS Taichman C Cooper ET Keller KJ Pienta NS Taichman 2002 Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone Cancer Res 62 1832 1837
55. G Yu GC Tseng YP Yu T Gavel J Nelson 2006 CSR1 suppresses tumor growth and metastasis of prostate cancer Am J Pathol 168 597 607
56. EB Jaeger RS Samant CW Rinker-Schaeffer 2004 Metastasis suppression in prostate cancer Cancer Metastasis Rev 20 279 286
57. AC Khodavirdi Z Song S Yang C Zhong S Wang 2006 Increased expression of osteopontin contributes to the progression of prostate cancer Cancer Res 66 883 888
58. DR Chesire WB Isaacs 2003 Beta-catenin signaling in prostate cancer: an early perspective Endocr Relat Cancer 10 537 560
59. RA Cardone V Casavola SJ Reshkin 2005 The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis Nat Rev Cancer 5 786 795
60. M Drobnjak I Osman HI Scher M Fazzari C Cordon-Cardo 2000 Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone Clin Cancer Res 6 1891 1895
61. P Uotila E Valve P Martikainen M Nevalainen M Nurmi 2001 Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer Urol Res 29 25 28
62. MD Lloyd DJ Darley AS Wierzbicki MD Threadgill 2008 Alpha-methylacyl-CoA racemase-an 'obscure' metabolic enzyme takes centre stage FEBS J 44 1089 1102
63. PJ Russell S Bennett P Stricker 1998 Growth factor involvement in progression of prostate cancer Clin Chem 44 705 723
64. RR Wei J Al-Bassam SC Harrison 2007 The Ndc80/HEC1 complex is a contact point for kinetochore-microtubule attachment Nat Struct Mol Biol 14 54 59
65. M Welcker BE Clurman 2007 FBW7 ubiquitin ligase: a tumor suppressor at the crossroads of cell division, growth and differentiation Nat Rev Cancer 8 83 93
66. D Floryk SL Tollaksen CS Giometti E Huberman 2004 Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5′-monophosphate dehydrogenase Cancer Res 64 9049 9056
67. C Hughes A Murphy C Martin O Sheils J O'Leary 2005 Molecular pathology of prostate cancer J Clin Pathol 58 673 684
68. H Meyera I Ahrens-Fathb A Sommera B Haendler 2004 Novel molecular aspects of prostate carcinogenesis Biomed Pharmacother 58 10 16
69. W Ren Z Qiao H Wang L Zhu L Zhang 2003 Flavonoids: promising anticancer agents Med Res Rev 23 519 534
70. N Kioka N Hosokawa T Komano K Hirayoshi K Nagata 1992 Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite FEBS Lett 301 307 309
71. K Igura T Ohta Y Kuroda K Kaji 2001 Resveratrol and quercetin inhibit angiogenesis in vitro Cancer Lett 171 11 16
72. I Romero A Páez A Ferruelo M Luján A Berenguer 2002 Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells BJU Inter 89 950 954
73. T Kobayashi T Nakata T Kuzumaki 2002 Effect of flavonoids on cell cycle progression in prostate cancer cells Cancer Lett 176 17 23
74. JD Lambert J Hong G Yang J Liao CS Yang 2005 Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations Am J Clin Nutr 81 284S 291S
75. K Murota A Hotta H Ido Y Kawai J Moon 2007 Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans J Med Invest 54 370 374
76. A Dihal R Woutersen B Ommen I Rietjens R Stierum 2006 Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2 Cancer Lett 238 248 259
77. T Okamoto 2005 Safety of quercetin for clinical application (review) Int J Mol Med 16 275 278
78. CK Donawho Y Luo Y Luo TD Penning JL Bauch 2007 ABT-888, an orally active poly(ADP-Ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models Clin Cancer Res 13 2728 2737
79. MR Kelley ML Fishel 2008 DNA repair proteins as molecular targets for cancer therapeutics Anti-Cancer Agents Med Chem 8 417 425
80. T Blunt NJ Finnie GE Taccioli GC Smith J Demengeot 1995 Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation Cell 80 813 823
81. MM Fuster JD Esko 2005 The sweet and sour of cancer: Glycans as novel therapeutic targets Nat Cancer Rev 5 526 542
82. M Yoshimura Y Ihara Y Matsuzawa N Taniguchi 1996 Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis J Biol Chem 271 13811 13815
83. R Adatia A Albini S Carlone D Giunciuglio R Benelli 1997 Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA Ann Oncol 8 1257 1261
84. E Zcharia S Metzger T Chajek-Shaul Y Friedmann O Pappo 2001 Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis J Mammary Gland Biol Neoplasia 6 311 322
85. B Ogretmen YA Hannun 2004 Biologically active sphingolipids in cancer pathogenesis and treatment Nat Rev Cancer 4 604 616
86. YA Hannun 1996 Functions of ceramide in coordinating cellular responses to stress Science 274 1855 1859
87. DE Bauer G Hatzivassiliou F Zhao C Andreadis CB Thompson 2005 ATP citrate lyase is an important component of cell growth and transformation Oncogene 24 6314 6322
88. E Graner D Tang S Rossi A Baron T Migita 2004 The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer Cancer Cell 5 253 261
89. L Chen KW Pankiewicz 2007 Recent development of IMP dehydrogenase inhibitors for the treatment of cancer Curr Opin Drug Discov Dev 10 403 412
90. GR Zimmermann J Lehár CT Keith 2007 Multi-target therapeutics: when the whole is greater than the sum of the parts Drug Discov Today 12 34 42
91. DC Altieri 2008 Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 8 61 70
92. CD Davis J Milner 2004 Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention Mut Res 551 51 64